Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2000
11/08/2000EP1049664A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
11/08/2000EP1049484A1 Method of using il-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
11/08/2000EP1049481A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
11/08/2000EP1049478A1 Composition containing propargylamine for enhancing cancer therapy
11/08/2000EP1049475A1 KINESIN MOTOR MODULATORS DERIVED FROM THE MARINE SPONGE $i(ADOCIA)
11/08/2000EP1049472A1 Antagonists of gonadotropin releasing hormone
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
11/08/2000EP1049464A2 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer
11/08/2000EP1049463A1 Use of fc101 as an angiogenesis inhibitor for the treatment of cancer and other angiogenic diseases
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP0789564A4 Polynucleotide compositions
11/08/2000EP0734396B1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272844A Benzo (5,6) cyclohepta (1,2-B) pyridine derivatives as farnesyl protein transferase inhibitors
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1272796A Polymeric derivatives of camptothecins
11/08/2000CN1272789A Pharmaceutical compositions for oral administration of molecular iodine
11/08/2000CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity
11/08/2000CN1058182C 抗癌丸 Anti-cancer pills
11/08/2000CN1058179C Traditional Chinese medicine for cancer of liver and its preparing method
11/08/2000CN1058166C Drug for curing leukopenia and radiation damage
11/07/2000US6143910 Methods for preparation and use of 1α, 24(S) -dihydroxy vitamin D2
11/07/2000US6143873 Monoclonal anti-multiple drug resistance antibody, methods of production and uses thereof
11/07/2000US6143867 Amino acid sequence; for diagnosis, prevention, and treatment of late-phase allergic/inflammatory reactions, eosinophilias, parasitic infections, conditions associated with placental derived-basic protein accumulation in pregnancy
11/07/2000US6143864 Peptides
11/07/2000US6143795 Stable mitoxantrone solutions
11/07/2000US6143779 Benzofuranone derivatives and a method for producing them
11/07/2000US6143776 Enzyme inhibitors of thymidylate synthase
11/07/2000US6143775 Physical form of zafirlukast; asthma
11/07/2000US6143770 Mixtures of tocotrienol and nicotinic acid
11/07/2000US6143758 Drugs for anticarcinogenic agents
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143740 Administering hergulin compound to inhibit cancer cell growth in mammals
11/07/2000US6143730 As anti-angiogenic, anti-metastatic and/or anti-inflammatory agents
11/07/2000US6143724 Used for treatment, improvement and prevention of inflammation and diseases accompanying inflamation
11/07/2000US6143722 To controll uterine contractions in treating preterm labor
11/07/2000US6143721 For treating cancer in mammals
11/07/2000US6143544 Human lysophospholipase
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000US6143326 Therapy for osteoporosis
11/07/2000US6143305 Antigenically modified polypeptides composition
11/07/2000US6143299 Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases
11/07/2000US6143292 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
11/07/2000US6143290 Tumor regression by adenovirus expression of wild-type p53
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2037933C Method of treatment with medical agents
11/02/2000WO2000065078A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
11/02/2000WO2000065073A2 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
11/02/2000WO2000065069A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064938A2 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000WO2000064936A2 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2
11/02/2000WO2000064934A1 Therapeutic compositions and methods for treating tumors
11/02/2000WO2000064900A1 Pyrazolobenzodiazepines as cdk2 inhibitors
11/02/2000WO2000064891A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064875A1 Method for pulvirizing to fine powder
11/02/2000WO2000064874A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/02/2000WO2000064870A1 3-methylated vitamin d derivatives
11/02/2000WO2000064869A1 Vitamin d analogues and their pharmaceutical use
11/02/2000WO2000064864A1 N-protected amines and their use as prodrugs
11/02/2000WO2000064863A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
11/02/2000WO2000064538A1 Products and methods for brachytherapy
11/02/2000WO2000064486A2 Enzymatically activated polymeric drug conjugates
11/02/2000WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome
11/02/2000WO2000064480A1 Treatment, imaging and diagnosis of disease using an agent which binds alfa5-integrin
11/02/2000WO2000064478A1 Preventives/remedies for liver diseases
11/02/2000WO2000064475A1 Treatment of metastatic cancer through mts-1 gene
11/02/2000WO2000064471A1 Model membrane systems
11/02/2000WO2000064467A1 Inhibition of proteasome function induces programmed cell death in endothelial cells
11/02/2000WO2000064465A1 Death domain containing receptors
11/02/2000WO2000064455A1 Method of enhancing the efficacy of anti-tumor agents
11/02/2000WO2000064431A1 Pharmaceutical compositions of tetrac and methods of use thereof
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000064414A2 Solid pharmaceutical formulations of acid-sensitive proton-pump blockers
11/02/2000WO2000064413A1 Antibody and polyalkylene glycol-bonded liposome
11/02/2000WO2000064260A1 Compositions and methods for treatment of hyperproliferative diseases
11/02/2000WO2000046235B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
11/02/2000WO2000042042A3 High affinity inhibitors for target validation and uses thereof
11/02/2000WO2000041726A3 Noninvasive vascular therapy
11/02/2000WO2000041516A3 Reagents and methods useful for detecting diseases of the breast
11/02/2000WO2000041508A3 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines
11/02/2000WO2000041482A3 Oral administration of taxoid derivatives
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040699A3 Astrocytes, their preparation and uses thereof
11/02/2000WO2000040271A3 P450 / acetaminophen gdept for cancer treatment
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039136A3 Human brainiac-5
11/02/2000WO2000039130A3 Prenyl transferase inhibitors
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000WO2000037640A9 Compositions and methods for the treatment of tumor
11/02/2000WO2000037504A9 Human monoclonal antibodies to ctla-4
1 ... 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 ... 2211